Ratings by Canaccord (Caitlin Cronin)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/16/2026 | Bioventus Inc | BVS | Maintain | Buy (Buy) |
|
Details | ||
| 2/26/2026 | Establishment Labs Inc. | ESTA | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2026 | AxoGen, Inc. | AXGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2026 | AxoGen, Inc. | AXGN | Maintain | Buy (Buy) |
|
Details | ||
| 12/17/2025 | InMode Ltd. | INMD | Maintain | Hold (N/A) |
|
Details | ||
| 12/17/2025 | Establishment Labs Inc. | ESTA | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2025 | AxoGen, Inc. | AXGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | Establishment Labs Inc. | ESTA | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | AxoGen, Inc. | AXGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2025 | Establishment Labs Inc. | ESTA | Maintain | Buy (Buy) |
|
Details | ||
| 10/10/2025 | InMode Ltd. | INMD | Maintain | Hold (N/A) |
|
Details | ||
| 10/2/2025 | AxoGen, Inc. | AXGN | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2025 | AxoGen, Inc. | AXGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2025 | Establishment Labs Inc. | ESTA | New Coverage | Buy (N/A) |
37.70 (87.01) |
130.8% | Details | |
| 7/31/2025 | Vericel Corporation | VCEL | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2025 | InMode Ltd. | INMD | Maintain | Hold (N/A) |
|
Details | ||
| 6/5/2025 | Vericel Corporation | VCEL | Maintain | Buy (Buy) |
|
Details | ||
| 5/13/2025 | Vericel Corporation | VCEL | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2025 | AxoGen, Inc. | AXGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2025 | InMode Ltd. | INMD | Maintain | Hold (N/A) |
|
Details | ||
| 4/15/2025 | InMode Ltd. | INMD | Maintain | Hold (Hold) |
|
Details | ||
| 4/1/2025 | Bioventus Inc | BVS | Maintain | Buy (Buy) |
|
Details | ||
| 2/3/2025 | Vericel Corporation | VCEL | Maintain | Buy (N/A) |
|
Details | ||
| 1/15/2025 | Vericel Corporation | VCEL | Maintain | Buy (Buy) |
|
Details | ||
| 1/8/2025 | InMode Ltd. | INMD | Maintain | Hold (Hold) |
|
Details | ||
| 1/2/2025 | Bioventus Inc | BVS | Maintain | Buy (Buy) |
|
Details | ||
| 11/11/2024 | Vericel Corporation | VCEL | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2024 | Vericel Corporation | VCEL | Maintain | Buy (Buy) |
|
Details | ||
| 11/6/2024 | Bioventus Inc | BVS | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2024 | InMode Ltd. | INMD | Maintain | Hold (N/A) |
|
Details | ||
| 10/1/2024 | InMode Ltd. | INMD | Maintain | Hold (N/A) |
|
Details | ||
| 10/1/2024 | Bioventus Inc | BVS | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | Vericel Corporation | VCEL | New Coverage | Buy (N/A) |
46.25 (40.39) |
-12.67% | Details | |
| 7/11/2024 | InMode Ltd. | INMD | Maintain | Hold (Hold) |
|
Details | ||
| 12/21/2023 | InMode Ltd. | INMD | Maintain | Hold (N/A) |
|
Details | ||
| 11/14/2023 | Vicarious Surgical inc. | RBOT | Downgrade | Hold (Buy) |
0.41 (1.92) |
368.29% | Details | |
| 10/13/2023 | InMode Ltd. | INMD | Downgrade | Hold (Buy) |
27.99 (13.35) |
-52.3% | Details |
